Table 3. Comparison of Adverse Events in Patients Receiving IVAPAP and Placebo.
| Outcomes | IVAPAP Group (n = 31) | Placebo Group (n = 29) | Difference % (95% CI) |
|---|---|---|---|
| Recovery speed, median (Q1, Q3), minutes | 45 (15, 60) | 45 (30, 60) | 0 (−23.7 to 23.7)a |
| Incidence of postoperation nausea, No. (%) | 13 (41.9) | 10 (34.5) | 7.5 (−17.1 to 32.0)b |
| Incidence of postoperation adverse events, No. (%) | 17 (54.8) | 16 (55.2) | −0.3 (−25.5 to 24.9)b |
| No. (%) of adverse events | NR | ||
| 0 | 14 (45.2) | 13 (44.8) | |
| 1 | 11 (35.5) | 11 (37.9) | |
| 2 | 6 (19.4) | 3 (10.3) | |
| 3 | 0 | 2 (6.9) |
Abbreviations: NR, not reported; Q1, 1st quartile; Q3, 3rd quartile.
a
Indicates the difference in median between 2 groups as well as its 95% CI.
b
Indicates the difference in percentage between 2 groups as well as its 95% CI.